{"DataElement":{"publicId":"5215083","version":"1","preferredName":"Opioid Agent Intravenous Administration Intravenous Name","preferredDefinition":"The name of the narcotic or opiate anesthetic agent administered within or into a vein or veins prior to organ removal in order to produce a total or partial loss of sensation especially tactile sensation and pain.","longName":"OPIATE_IV_NAME","context":"BBRB","contextVersion":"1","DataElementConcept":{"publicId":"5211139","version":"1","preferredName":"Opioid Agent Intravenous Administration","preferredDefinition":"A class of synthetic chemicals/drugs similar to opiates (opium derivatives) with analgesic properties.  Due to binding to opiate receptors, opioids mimic opiate activity on neurons, various cells (i.e. lymphocytes), pain suppression and other neurobehavioral activity. (NCI)_An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._Into or within a vein. Intravenous usually refers to a way of giving a drug or other substance through a needle or tube inserted into a vein._The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","longName":"2718836v1.0:2717633v1.0","context":"BBRB","contextVersion":"1","ObjectClass":{"publicId":"2718836","version":"1","preferredName":"Opioid Agent","preferredDefinition":"A class of synthetic chemicals/drugs similar to opiates (opium derivatives) with analgesic properties.  Due to binding to opiate receptors, opioids mimic opiate activity on neurons, various cells (i.e. lymphocytes), pain suppression and other neurobehavioral activity. (NCI):An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C1506:C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Opioid","conceptCode":"C1506","definition":"A class of synthetic chemicals/drugs similar to opiates (opium derivatives) with analgesic properties.  Due to binding to opiate receptors, opioids mimic opiate activity on neurons, various cells (i.e. lymphocytes), pain suppression and other neurobehavioral activity. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42EB9310-55BA-1555-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-01-04","modifiedBy":"ONEDATA","dateModified":"2008-01-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2717633","version":"1","preferredName":"Intravenous Administration","preferredDefinition":"(in-tra-VEE-nus) IV. Within a blood vessel.:The act of administration.","longName":"C13346:C25409","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intravenous","conceptCode":"C13346","definition":"Into or within a vein. Intravenous usually refers to a way of giving a drug or other substance through a needle or tube inserted into a vein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administration","conceptCode":"C25409","definition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42624FF7-0150-68FE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-12-28","modifiedBy":"ONEDATA","dateModified":"2007-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435024","version":"1","preferredName":"Drug or Chemical","preferredDefinition":"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and/or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life.","longName":"C1908","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB04-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC9BDDD-32D0-501F-E050-BB89AD434E5A","latestVersionIndicator":"Yes","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-06","modifiedBy":"HARTLEYG","dateModified":"2016-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5212058","version":"1","preferredName":"Intravenous Narcotic Opiate Agent Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"5212058v1.0","context":"BBRB","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other Narcotics/Opiates (specify)","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FD7CF95-9503-38AC-E050-BB89AD436C35","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-06","modifiedBy":"ONEDATA","dateModified":"2016-04-06","deletedIndicator":"No"},{"value":"Morphine","valueDescription":"Morphine","ValueMeaning":{"publicId":"5211114","version":"1","preferredName":"Morphine","longName":"5211114","preferredDefinition":"An opiate alkaloid isolated from the plant Papaver somniferum and produced synthetically. Morphine binds to and activates specific opiate receptors (delta, mu and kappa), each of which are involved in controlling different brain functions. In the central nervous and gastrointestinal systems, this agent exhibits widespread effects including analgesia, anxiolysis, euphoria, sedation, respiratory depression, and gastrointestinal system smooth muscle contraction. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Morphine","conceptCode":"C62051","definition":"An opiate alkaloid isolated from the plant Papaver somniferum and produced synthetically. Morphine binds to and activates specific opiate receptors (delta, mu and kappa), each of which are involved in controlling different brain functions. In the central nervous and gastrointestinal systems, this agent exhibits widespread effects including analgesia, anxiolysis, euphoria, sedation, respiratory depression, and gastrointestinal system smooth muscle contraction. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC947D3-EE23-E06C-E050-BB89AD4321A6","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FD7CF95-950D-38AC-E050-BB89AD436C35","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-06","modifiedBy":"ONEDATA","dateModified":"2016-04-06","deletedIndicator":"No"},{"value":"Meperidine","valueDescription":"Meperidine","ValueMeaning":{"publicId":"5211116","version":"1","preferredName":"Meperidine","longName":"5211116","preferredDefinition":"A synthetic piperidine ester with opioid analgesic activity. Meperidine mimics the actions of endogenous neuropeptides via opioid receptors, thereby producing the characteristic morphine-like effects on the mu-opioid receptor, including analgesia, euphoria, sedation, respiratory depression, miosis, bradycardia and physical dependence.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Meperidine","conceptCode":"C71632","definition":"A synthetic piperidine ester with opioid analgesic activity. Meperidine mimics the actions of endogenous neuropeptides via opioid receptors, thereby producing the characteristic morphine-like effects on the mu-opioid receptor, including analgesia, euphoria, sedation, respiratory depression, miosis, bradycardia and physical dependence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC947D3-EE49-E06C-E050-BB89AD4321A6","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FD7CF95-9517-38AC-E050-BB89AD436C35","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-06","modifiedBy":"ONEDATA","dateModified":"2016-04-06","deletedIndicator":"No"},{"value":"Hydromorphone","valueDescription":"Hydromorphone","ValueMeaning":{"publicId":"5211118","version":"1","preferredName":"Hydromorphone","longName":"5211118","preferredDefinition":"The hydrogenated ketone of morphine, a semi-synthetic opioid with analgesic effects. Hydromorphone selectively binds the mu-opioid receptor which is linked through G-proteins. Binding stimulates the exchange of guanosine triphosphate (GTP) for guanosine diphosphate (GDP) on the G-protein complex and interacts with and inhibits adenylate cyclase located at the inner surface of the plasma membrane. This leads to a reduction in intracellular cyclic 3',5'-adenosine monophosphate (cAMP). Further, voltage-gated potassium channels are activated, thereby causing hyperpolarization and reducing neuronal excitability. In addition, the opening of voltage-gated calcium channels is inhibited, thereby leading to an inhibition of calcium entry and a reduction in the release of various neurotransmitters, including GABA, vasopressin, somatostatin, insulin and glucagons.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hydromorphone","conceptCode":"C62034","definition":"The hydrogenated ketone of morphine, a semi-synthetic opioid with analgesic effects. Hydromorphone selectively binds the mu-opioid receptor which is linked through G-proteins. Binding stimulates the exchange of guanosine triphosphate (GTP) for guanosine diphosphate (GDP) on the G-protein complex and interacts with and inhibits adenylate cyclase located at the inner surface of the plasma membrane. This leads to a reduction in intracellular cyclic 3',5'-adenosine monophosphate (cAMP). Further, voltage-gated potassium channels are activated, thereby causing hyperpolarization and reducing neuronal excitability. In addition, the opening of voltage-gated calcium channels is inhibited, thereby leading to an inhibition of calcium entry and a reduction in the release of various neurotransmitters, including GABA, vasopressin, somatostatin, insulin and glucagons.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC947D3-EE6F-E06C-E050-BB89AD4321A6","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FD7CF95-9521-38AC-E050-BB89AD436C35","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-06","modifiedBy":"ONEDATA","dateModified":"2016-04-06","deletedIndicator":"No"},{"value":"Fentanyl","valueDescription":"Fentanyl","ValueMeaning":{"publicId":"2576850","version":"1","preferredName":"Fentanyl","longName":"2576850","preferredDefinition":"A narcotic opioid drug that is used in the treatment of pain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fentanyl","conceptCode":"C494","definition":"A synthetic, lipophilic phenylpiperidine opioid agonist with analgesic and anesthetic properties. Fentanyl selectively binds to and activates the mu-receptor in the central nervous system (CNS) thereby mimicking the effects of endogenous opiates. Activation of the mu-subtype opioid receptor stimulates the exchange of GTP for GDP on the G-protein complex and subsequently inhibits adenylate cyclase. This causes a decrease in intracellular cAMP which inhibits cAMP-mediated calcium influx into the cell via the calcium channels and thereby results in hyperpolarization and reduced neuronal excitability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F93F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-11-08","modifiedBy":"ONEDATA","dateModified":"2005-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FD7CF95-952B-38AC-E050-BB89AD436C35","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-06","modifiedBy":"ONEDATA","dateModified":"2016-04-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435024","version":"1","preferredName":"Drug or Chemical","preferredDefinition":"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and/or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life.","longName":"C1908","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB04-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2229718","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F6EF4E2B-76AE-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-16","modifiedBy":"ONEDATA","dateModified":"2005-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FD7CF95-94E3-38AC-E050-BB89AD436C35","latestVersionIndicator":"Yes","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-06","modifiedBy":"HARTLEYG","dateModified":"2016-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"5188870","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB","ClassificationSchemeItems":[{"publicId":"5405791","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB"},{"publicId":"6736434","version":"1","longName":"Lung Surgery-Anesthesia","context":"BBRB"},{"publicId":"6736433","version":"1","longName":"Kidney Surgery-Anesthesia","context":"BBRB"},{"publicId":"6736432","version":"1","longName":"Colon Surgery-Anesthesia","context":"BBRB"},{"publicId":"6736435","version":"1","longName":"Ovary Sugery-Anesthesia","context":"BBRB"}]}],"AlternateNames":[{"name":"COG","type":"USED_BY","context":"COG"},{"name":"BBRB","type":"USED_BY","context":"BBRB"}],"ReferenceDocuments":[{"name":"IV Narcotic/Opiate Agents","type":"Preferred Question Text","description":"IV Narcotic/Opiate Agents","url":null,"context":"BBRB"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Name of Opioid Agent given:","url":null,"context":"COG"}],"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2FEA0C5F-18EA-F37D-E050-BB89AD43280F","latestVersionIndicator":"Yes","beginDate":"2016-04-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-07","modifiedBy":"HARTLEYG","dateModified":"2019-04-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}